Capricor Therapeutics (CAPR) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CAPR Hot Sheet
Join SI Premium – FREE
Capricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Zhongchao to execute 1-for-3 share consolidation on Nasdaq
- Yiren Digital Ltd. (YRD) Reports Q1 Loss of RMB5.64
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
